Conexeu Sciences Inc. is a biotechnology company dedicated to the discovery, development, and commercialization of novel therapies for patients facing complex and life-threatening conditions. Operating primarily in the United States and listed on the NASDAQ, the company focuses on leveraging advanced biological insights and proprietary technology platforms to build a robust pipeline of drug candidates. Conexeu Sciences operates within the healthcare sector, specifically targeting the biotechnology and life sciences industry group. Its research and development efforts are centered on identifying unique biological pathways to treat diseases in areas such as oncology, inflammatory disorders, and other specialized therapeutic fields. The company's strategy involves advancing its candidates through rigorous clinical trials while seeking strategic partnerships to accelerate the delivery of its innovations to the global market. By prioritizing precision medicine and high-impact therapeutic areas, Conexeu Sciences aims to improve patient outcomes and provide value to its stakeholders. The company is led by a team of experienced professionals in the biopharmaceutical space who are committed to scientific excellence and the advancement of next-generation medical treatments.
The sum of declared dividends issued by a company for every ordinary share outstanding.
Dividend Yield is a financial ratio that shows how much a company pays out in dividends each year relative to its share price in the last twelve months. In the absence of any capital gains, the dividend yield is the return on investment for a stock.
It is another way that companies have to remunerate their shareholders, being an alternative to dividends. Shows the % of repurchases per share made in the last 12 months in relation to the share price.
Sum of Dividend Yield and BuyBack Yield to show the total return that the shareholder received in the last 12 months in relation to the share price.
The dividend payout ratio is the ratio of the total amount of dividends paid out to shareholders relative to the net income of the company. It is the percentage of earnings paid to shareholders via dividends.
Retained earnings (RE) are the amount of net income left over for the business after it has paid out dividends to its shareholders and are an important variable for assessing a company's financial health because it shows the net income that a company has saved over time, and therefore has the ability to reinvest in the business or distribute to shareholders.
...and much more!